Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects

Clinical trial NCT04309734 · WITHDRAWN

Trial details

NCT number: NCT04309734
Sponsor: Atea Pharmaceuticals, Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatitis C Hepatitis C, Chronic Chronic Hepatitis C Hepatitis C Virus Infection HCV Infection

Start date: 2021-10-01
Primary completion: 2022-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.